TCL Archive Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer August 27, 2010
TCL Archive Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity October 28, 2011
TCL Archive In Brief: Streamlining Of Contract Award Process Still Top Priority At NCI; Training Grants No Closer January 10, 1975
TCL Archive NCI Receives 165 SBIR Grant Applications; Combines With Solid Contracts, No More Fiascos Are Expected June 14, 1985
